We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

This summer, agrochemical, biotechnology and seed giant Monsanto dropped its bid to acquire its Switzerland-based competitor, Syngenta. Initial merger serenades were sternly rebuffed by Syngenta, ...

Dammit, Ben Stiller, there you go making me use my brain during my relaxing TV time. 'Severance' made me rethink why I run.

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

groninger, a German manufacturer of filling and closing machines for the pharmaceutical, consumer healthcare and cosmetics industries, is expanding its U.S. headquarters in Charlotte. groninger USA ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Could you tell me about the firm? Mr. Kennedy: AllSource is a firm that focuses on high-net-worth and ultra-high-net-worth families, and we specialize in alternative investments. We like to say we ...

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

Budget amendments from the governor and the House of Delegates both include $5 million in funding for the Roanoke project.

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...